Health Minister Adel Adawy said on Saturday that the ministry would give priority of applying a new hepatitis C virus (HCV) treatment on patients who suffer acute infection.
Addressing a press conference Saturday, the minister said Sovaldi drug would be given to patients who suffer long infection with the deadly virus.
Sovaldi’s success rate with hepatitis C patients was over 90 per cent, said the minister, adding the government would not spare effort to provide new drugs to the patients.
Also, the higher committee of combating tumors set the special regulations of cancerous tumors' treatments, he said.
Rates of people who catch the liver viruses are steadily increasing, the minister said, adding the new drug would be available in September.